Toggle navigation
Data Resources
Computing Analysis
Data Network
Standards
OpenLB
Open Library of Bioscience
Search
Advanced Search
Journal
Select Journal
Publication Year
1 year
3 years
5 years
10 years
From
2021 - 2032
2021
2022
2023
2024
2025
2026
2027
2028
2029
2030
2031
2032
To
2021 - 2032
2021
2022
2023
2024
2025
2026
2027
2028
2029
2030
2031
2032
Publication Type
Case Reports
Comment
Comparative Study
Editorial
Letter
Journal Article
Review
Preprint
Associated Data
YES
Found 15,344 results
Sort by:
Best match
Best match
Most recent
Publication date
Filters:
Macrolide
Prevalence of macrolide resistance in Treponema pallidum is associated with macrolide consumption.
Chris Kenyon
J Med Microbiol
. Feb, 2019.68(2):119-123 Print-Electronic
Source:PubMed
PMID:
30520715
doi:10.1099/jmm.0.000885
Annual macrolide prescription rates and the emergence of macrolide resistance among Streptococcus pneumoniae in Canada from 1995 to 2005.
James A Karlowsky, Philippe R S Lagacé-Wiens, Donald E Low, George G Zhanel
Int J Antimicrob Agents
. Oct, 2009.34(4):375-9 Print-Electronic
Source:PubMed
PMID:
19560902
doi:10.1016/j.ijantimicag.2009.05.008
[Recent advances in the study of macrolide glycosyltransferases].
Dong-Mei Liang, Jian-Jun Qiao
Yao Xue Xue Bao
. May, 2007.42(5):455-62 Print
Source:PubMed
PMID:
17703764
doi:
Is there a resistance-threshold for macrolide consumption? Positive evidence from an ecological analysis of resistance data from Streptococcus pneumoniae, Treponema pallidum and Mycoplasma genitalium
Kenyon, C.; Van Dijck, C.; Basil, S.
medrxiv
. 2020-10-14. Preprint
Source:medrxiv
PPRID:
10.1101/2020.10.13.20212043v1
doi:10.1089/mdr.2020.0490
Macrolide-resistant Campylobacter: the meat of the matter.
Aimee E Belanger, Thomas R Shryock
J Antimicrob Chemother
. Oct, 2007.60(4):715-23 Print-Electronic
Source:PubMed
PMID:
17704515
doi:10.1093/jac/dkm300
Development of macrolide resistance-associated mutations after macrolide treatment in children infected with Mycoplasma pneumoniae.
Yu Suzuki, Yoshitaka Shimotai, Tsutomu Itagaki, Junji Seto, Tatsuya Ikeda, Kazue Yahagi, Katsumi Mizuta, Seiji Hongo, Yoko Matsuzaki
J Med Microbiol
. Nov, 2017.66(11):1531-1538 Print-Electronic
Source:PubMed
PMID:
28984229
doi:10.1099/jmm.0.000582
Macrolide versus Non-Macrolide in Combination with Steroids for the Treatment of Lobar or Segmental Pneumonia Unresponsive to Initial Macrolide Monotherapy.
Eunha Bae, Ye Ji Kim, Hyun Mi Kang, Dae Chul Jeong, Jin Han Kang
Antibiotics (Basel)
. Sep 10, 2022.11(9): Electronic
Source:PubMed
PMID:
36140012
doi:10.3390/antibiotics11091233
Population genomic molecular epidemiological study of macrolide resistant Streptococcus pyogenes in Iceland,1995-2016: Identification of a large clonal population with a pbp2x mutation conferring reduced in vitro beta-lactam susceptibility
Southon, S. B.; Beres, S. B.; Kachroo, P.; Ojeda Saavedra, M.; Erlendsdottir, H.; Haraldsson, G.; Yerramilli, P.; Pruitt, L.; Zhu, L.; Musser, J. M.; Kristinsson, K. G.
biorxiv
. 2020-05-13. Preprint
Source:biorxiv
PPRID:
10.1101/2020.05.12.090365v1
doi:10.1128/JCM.00638-20
Monotherapy: Key cause of macrolide-resistant Mycobacterium avium complex disease.
Daniel Loewenstein, Lars van Balveren, Arthur Lemson, Nicolien Hanemaaijer, Wouter Hoefsloot, Jakko van Ingen
Respir Med
. 10, 2023.217:107366 Print-Electronic
Source:PubMed
PMID:
37481170
doi:10.1016/j.rmed.2023.107366
P. acnes qPCR-based antibiotics resistance assay (ACQUIRE) reveals widespread macrolide resistance in acne patients and can eliminate macrolide misuse in acne treatment
Zhang, J.
medrxiv
. 2021-06-25. Preprint
Source:medrxiv
PPRID:
10.1101/2021.06.21.21256023v1
doi:NA
0
Previous
Next